Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

CG Oncology (CGON) Operating Margin: 2023-2025

Historic Operating Margin for CG Oncology (CGON) over the last 2 years, with Sep 2025 value amounting to -3,068.97%.

  • CG Oncology's Operating Margin rose 6273336.00% to -3,068.97% in Q3 2025 from the same period last year, while for Sep 2025 it was -8,124.63%, marking a year-over-year increase of 590637.00%. This contributed to the annual value of -10,067.25% for FY2024, which is 1711363.00% up from last year.
  • Latest data reveals that CG Oncology reported Operating Margin of -3,068.97% as of Q3 2025, which was up 96.22% from -81,161.54% recorded in Q1 2025.
  • In the past 5 years, CG Oncology's Operating Margin registered a high of -3,068.97% during Q3 2025, and its lowest value of -1,935,500.00% during Q4 2023.
  • Moreover, its 3-year median value for Operating Margin was -23,290.99% (2024), whereas its average is -253,606.61%.
  • Its Operating Margin has fluctuated over the past 5 years, first skyrocketed by 192,715,592bps in 2024, then tumbled by 7,691,409bps in 2025.
  • CG Oncology's Operating Margin (Quarterly) stood at -1,935,500.00% in 2023, then soared by 192,715,592bps to -8,344.08% in 2024, then spiked by 6,273,336bps to -3,068.97% in 2025.
  • Its Operating Margin was -3,068.97% in Q3 2025, compared to -81,161.54% in Q1 2025 and -8,344.08% in Q4 2024.